Compounds > methylthio-adp

Page last updated: 2024-09-03

methylthio-adp and adenosine 5'-o-(3-thiotriphosphate)

methylthio-adp has been researched along with adenosine 5'-o-(3-thiotriphosphate) in 8 studies

Compound Research Comparison

Studies (methylthio-adp)	Trials (methylthio-adp)	Recent Studies (post-2010) (methylthio-adp)	Studies (adenosine 5'-o-(3-thiotriphosphate))	Trials (adenosine 5'-o-(3-thiotriphosphate))	Recent Studies (post-2010) (adenosine 5'-o-(3-thiotriphosphate))
146	2	43	975	0	120

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jacobson, KA; Jarvis, MF; Williams, M	1
Greve, H; Kassack, MU; Kehraus, S; König, GM; Krick, A; Meis, S; Wright, AD	1
Azran, S; Danino, O; Fischer, B; Förster, D; Nadel, Y; Reiser, G	1
Breittmayer, JP; Frelin, C; Gachet, C; Hechler, B; Vigne, P	1
Chambers, JK; Emson, PC; Moore, DJ; Murdock, PR	1
Edvinsson, L; Erlinge, D; Hou, M; Malmsjö, M; Pendergast, W	1
Bender, SB; Berwick, ZC; Laughlin, MH; Tune, JD	1
Förster, D; Reiser, G	1

Reviews

1 review(s) available for methylthio-adp and adenosine 5'-o-(3-thiotriphosphate)

Article	Year
Purine and pyrimidine (P2) receptors as drug targets. Journal of medicinal chemistry, 2002, Sep-12, Volume: 45, Issue:19 Topics: Adenosine Triphosphate; Animals; Drug Design; Humans; Ligands; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P2; Uridine Triphosphate	2002

Other Studies

7 other study(ies) available for methylthio-adp and adenosine 5'-o-(3-thiotriphosphate)

Article	Year
New iantherans from the marine sponge Ianthella quadrangulata: novel agonists of the P2Y(11) receptor. Journal of medicinal chemistry, 2007, Nov-15, Volume: 50, Issue:23 Topics: Animals; Benzofurans; Calcium; Cell Line, Tumor; Humans; Ligands; Models, Molecular; Porifera; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Structure-Activity Relationship; Sulfuric Acid Esters; Tyrosine	2007
Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists. Journal of medicinal chemistry, 2013, Jun-27, Volume: 56, Issue:12 Topics: Animals; Antioxidants; Biocompatible Materials; Drug Design; Drug Stability; Humans; Hydrolysis; Models, Molecular; Neuroprotective Agents; Nucleotides; PC12 Cells; Protein Conformation; Purinergic P2Y Receptor Agonists; Rats; Reactive Oxygen Species; Receptors, Purinergic P2Y	2013
Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Biochemical and biophysical research communications, 1999, Mar-05, Volume: 256, Issue:1 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Brain; Calcium; Cholera Toxin; Cyclic AMP; Endothelium, Vascular; Humans; Inhibitory Concentration 50; Jurkat Cells; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Signal Transduction; Thionucleotides; Transfection	1999
Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor. Neuropharmacology, 2002, Volume: 43, Issue:6 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Antineoplastic Agents; Blotting, Western; Calcium; Cell Membrane; Cells, Cultured; Cyclic AMP; Fluorescence; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Humans; Membrane Proteins; Mitogen-Activated Protein Kinases; Neurons; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Receptors, Purinergic P2Y2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Suramin; Thionucleotides; Uridine Triphosphate	2002
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors. European journal of pharmacology, 2003, Jan-05, Volume: 458, Issue:3 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Basilar Artery; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; In Vitro Techniques; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thionucleotides; Uridine Diphosphate; Uridine Triphosphate; Vasoconstriction	2003
Functional contribution of P2Y1 receptors to the control of coronary blood flow. Journal of applied physiology (Bethesda, Md. : 1985), 2011, Volume: 111, Issue:6 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arterioles; Blood Flow Velocity; Coronary Circulation; Dogs; Hyperemia; In Vitro Techniques; Male; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y1; Thionucleotides; Vasodilation	2011
Nucleotides protect rat brain astrocytes against hydrogen peroxide toxicity and induce antioxidant defense via P2Y receptors. Neurochemistry international, 2016, Volume: 94 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Animals, Newborn; Antioxidants; Cell Survival; Cells, Cultured; Cytoprotection; Hydrogen Peroxide; Neuroprotective Agents; Nucleotides; Rats; Receptors, Purinergic P2Y; Thionucleotides	2016